I know that we have a lot of retailers invested in CYDY

New Post Public Reply Private Reply Replies (1) Message Board
HCIT
589
I know that we have a lot of retailers invested in CYDY stock, 43K of us prior to June 2021 and we've all have done our research on CYDY. We all invested for similar reasons, the great potential of Leronlimab and we all see the potential, and we all know how undervalued it is.

I know we all see how CYDY keeps dropping and none of us bullish investors can figure out a plausible reason for the stock to keep dropping day after day from all of the negative law suits, hit pieces & the previous revenge nerd activists. Then, as I have seen along with many others it’s obviously being manipulated to death most likely by these types above in this paragraph.

I have listened to what many others have said about CYDY's decline. If they’re presenting a coherent argument for the stock’s decline, backed up by data and a reasonable thesis, that’s totally different, but that is not the case with our trials. Our trials have shown proof that Leronlimab works -++++.

But IMO, if you all see what I see and are as bewildered as I am by the stock’s movement downward for weeks now, then you have to see that CYDY is being manipulated by parasites.

As I have seen for years as an investor, that an unmanipulated market is some what normally a rational place. It follows the laws of supply and demand. I and I'm sure many here see these manipulators distort these markets by faking supply (dumping shares), faking demand (pumping garbage), and faking sentiment (posting fake comments, as we've seen on Ihub like I have seen and am sure many of you too have all seen.)

That is why I have been saying since June how the bid & ask is being manipulated to force shares down constantly until they can't do it any longer. That place in time will come for sure when our trials will show that Leronlimab is proof of concept! Leronlimab works. Then shares will reverse from here and start moving upwards. When the proof is finally shown, this manipulation will stop until we get to $10/share or more. Sure, manipulation always occurs and will again rear it's ugly head for some other reason but we will already have proof of concept so the manipulators may have to find another home to perform their ugly magic.

If we are investing for the short term (less than five years or so) then we must expect these shenanigans from these manipulators for they are not going away anytime soon. IMO, being here for over 5 years, all I can say is disregard the manipulation and wait for the science to prove out entirely. I have bought my shares for years and averaged way down in 2019 until I ran out of powder to buy more.

So, all I can say to anyone willing to listen, is to buy and hold and do not look back. The science will show it's beautiful head some day soon and that should start as the Brazilian trials start enrolling until we hit the interim time to looksee and, if necessary, make any adjustments to the trials so the endpoints are met at the end of the trial. Again, hold on tight for this manipulation will not stop until we get some news of substance proving Leronlimabs efficacy. Again, this is my opinion only but I've seen the proof already and NO ONE is GOING to take MY SHARES from me, period - GLTA

HCIT

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
https://media.gettyimages.com/photos/the-grea...wdoE_swYM=
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Havfram's Transition to DEME: A New Era in Offshore Wind Energy

Updated Category News Views 288

Strategic Sale of Havfram to DEME Announced In an exciting development in the offshore wind sector, Sandbrook Capital and the Public Sector Pension Investment Board (PSP Investments) have reached an agreement to sell their offshore wind infrastructure company, Havfram, to DEME, a prominent player in offshore energy and marine engineering. This strategic move is poised to...

Continue Reading
Exploring Automotive Fuel Cells: Future Market Growth Insights

Updated Category News Views 162

Overview of the Automotive Fuel Cell Market The automotive fuel cell market is experiencing an impressive trajectory as it evolves into a critical segment in the automotive industry. Fuel cells are electrochemical devices that produce electricity through the reactions of hydrogen and oxygen, making them a clean alternative to conventional combustion engines. Their ability...

Continue Reading
Women's Lacrosse League Teams to Compete in Exciting Debut

Updated Category News Views 304

Women's Lacrosse League Introduces Inaugural Teams The Women's Lacrosse League (WLL) has recently introduced its four inaugural teams: the Boston Guard, New York Charging, Maryland Charm, and California Palms. These teams were established after extensive research into market analysis, taking into consideration factors such as broadcast viewership, existing women's...

Continue Reading
Lifeway Foods Expects Impressive Q3 Net Sales Growth of $55.8M-$57M

Updated Category News Views 114

Lifeway Foods' Impressive Sales Projection for Third Quarter Lifeway Foods, Inc. (NASDAQ: LWAY) has recently announced that it expects to achieve estimated unaudited net sales ranging from $55.8 million to $57.0 million for its upcoming third quarter. This anticipated result highlights a remarkable increase of between 21% and 24% compared to the same quarter from the...

Continue Reading
Transforming Nonprofit Fundraising with Innovative Solutions

Updated Category News Views 160

Instil Launches Major Gift Solution for Nonprofits Instil Inc. has recently unveiled its cutting-edge Major Gift Solution aimed at empowering enterprise nonprofits to revolutionize their fundraising strategies. By focusing on major gifts and leveraging the capabilities of Salesforce, this innovative solution provides organizations the tools they need to effectively manage...

Continue Reading